⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

CRL

Charles River Laboratories International, Inc.

Healthcare · Diagnostics & Research

278.35USD

-2.4100 (-0.86%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 278.35
P/E—
Dvd Ind Yld—
P/B4.72
P/S3.4
Curr EV/T12M EBITDA42.0
Mkt Cap (USD)13.4B
Curr EV (USD)16.3B
2)

Per Share Data

EPS T12M-4.81
DPS—
Bk Val Per Sh59.50
Rev/Sh83.28
Cash/Sh4.02
Curr Shares Out48.2M
FCF/Sh7.72
3)

Cash Flow Analysis

P/CF23.0
Curr P/FCF36.2
CF/NI-2.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales14.6%
Eff Interest Rate3823.7%
4)

Growth Potential

Dil EPS 1Y Gr-1555.0%
Cap 1Y Gr-8.6%
BPS 1Y Gr-4.8%
R&D To Sales—
Retention Rate100.0%
Rev 1Y Gr-0.9%
FCF 1Y Gr3.4%
Assets 1Y Gr-5.2%
5)

Profitability

EBITDA0.4B
EBIT0.1B
Operating Margin2.3%
Pretax Margin7.6%
Net Margin-6.0%
ROA-3.2%
ROE-7.7%
ROC1.7%
Asset Turnover0.53
6)

Structure

Current Ratio1.35
Quick Ratio0.80
Debt/Assets21.7%
Debt/Com Eq57.5%
Net Debt/EBITDA3.71
Tot Debt/Capital36.5%
Gross Margin35.2%
EBIT/Int Exp0.8

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.